The PV guideline amendments may not be applied on Jan. 1st

By Lee, Hye-Kyung | translator Alice Kang

21.12.22 12:02:20

가나다라 0

Schedule coincides with the NHIS’ internal reorganization schedule such as the personnel appointments, etc.

Also, more time is required to review the industry’s opinion statement due to strong opposition from the industry

It is believed that the improvement of the detailed guidelines for the Price-Volume agreement negotiations (PV) prepared by the National Health Insurance Service may not be implemented on January 1st of next year.

This is in part due to the authorities’ internal affairs including its reorganization schedules, but also due to the strong opposition shown by the industry regarding the amendment.

However, the NHIS plans to finish the guideline amendments through discussion with the Ministry of Health and Welfare by February next year when the selection of pharmaceuticals subject to monitoring for PV negotiations begins.

The NHIS had presented a plan on improving the PV negoti

Lee, Hye-Kyung(hgrace7@dailypharm.com)

If you want to see the full article, please JOIN US (click)